These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 10037167

  • 1. New vs. old antipsychotics: the Texas experience.
    Reid WH.
    J Clin Psychiatry; 1999; 60 Suppl 1():23-5; discussion 28-30. PubMed ID: 10037167
    [Abstract] [Full Text] [Related]

  • 2. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R, Cramer J, Xu W, Thomas J, Henderson W, Frisman L, Fye C, Charney D.
    N Engl J Med; 1997 Sep 18; 337(12):809-15. PubMed ID: 9295240
    [Abstract] [Full Text] [Related]

  • 3. Clozapine for refractory schizophrenia: the Illinois experience.
    Buckman RW, Malan RD.
    J Clin Psychiatry; 1999 Sep 18; 60 Suppl 1():18-22; discussion 28-30. PubMed ID: 10037166
    [Abstract] [Full Text] [Related]

  • 4. The pharmacoeconomics of clozapine: a review.
    Meltzer HY, Cola PA.
    J Clin Psychiatry; 1994 Sep 18; 55 Suppl B():161-5. PubMed ID: 7961564
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T, Weinbrenner S, Busse R, Juckel G, Gericke CA.
    J Ment Health Policy Econ; 2008 Jun 18; 11(2):89-97. PubMed ID: 18509216
    [Abstract] [Full Text] [Related]

  • 6. [Medico-economic evaluation of treatment with clozapine versus treatment with previous neuroleptics].
    Geronimi-Ferret D, Lesay M, Barges-Bertocchio MH, Cornet-Bonnefont M, Robert H.
    Encephale; 1997 Sep 18; 23 Spec No 4():24-31. PubMed ID: 9417402
    [Abstract] [Full Text] [Related]

  • 7. [The impact of antipsychotic medication on the incidence and the costs of inpatient treatment in people with schizophrenia: results from a prospective observational study].
    Kilian R, Angermeyer MC.
    Psychiatr Prax; 2004 Apr 18; 31(3):138-46. PubMed ID: 15042477
    [Abstract] [Full Text] [Related]

  • 8. [Medico-economic study of Léponex (clozapine) in the Bordeaux Charles Perrens Hospital Center].
    Bret P, Jolivel C, Bret MC, Veylit S, Martin C, Garcia P.
    Encephale; 1998 Apr 18; 24(4):365-77. PubMed ID: 9809242
    [Abstract] [Full Text] [Related]

  • 9. A pharmacoeconomic analysis of atypical antipsychotics and haloperidol in first-episode schizophrenic patients in taiwan.
    Gau SS, Chung CH, Gau CS.
    J Clin Psychopharmacol; 2008 Jun 18; 28(3):271-8. PubMed ID: 18480683
    [Abstract] [Full Text] [Related]

  • 10. Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R, Cramer J, Xu W, Grabowski J, Douyon R, Thomas J, Henderson W, Charney D.
    Health Serv Res; 1998 Dec 18; 33(5 Pt 1):1237-61. PubMed ID: 9865219
    [Abstract] [Full Text] [Related]

  • 11. Psychiatric hospital utilization in patients treated with clozapine for up to 4.5 years in a state mental health care system.
    Reid WH, Mason M.
    J Clin Psychiatry; 1998 Apr 18; 59(4):189-94. PubMed ID: 9590670
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A pharmacoeconomic evaluation of clozapine in one patient.
    Rémillard AJ, Johnson JA.
    Can J Hosp Pharm; 1993 Jun 18; 46(3):115-9. PubMed ID: 10126866
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
    Chen H, Kennedy WK, Dorfman JH, Fincham JE, Reeves J, Martin BC.
    Curr Med Res Opin; 2007 Jun 18; 23(6):1351-65. PubMed ID: 17559734
    [Abstract] [Full Text] [Related]

  • 16. Pharmacoeconomic evaluation of treatments for refractory schizophrenia: clozapine-related studies.
    Revicki DA.
    J Clin Psychiatry; 1999 Jun 18; 60 Suppl 1():7-11; discussion 28-30. PubMed ID: 10037164
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hospitalization resource utilization and costs among Medicaid insured patients with schizophrenia with different treatment durations of long-acting injectable antipsychotic therapy.
    Bera R, Offord S, Zubek D, Lau G, Lin J, Karson C.
    J Clin Psychopharmacol; 2014 Feb 18; 34(1):30-5. PubMed ID: 24135840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.